Meeting
2023 ASCO Genitourinary Cancers Symposium
Identification of lineage-specific transcription factor defined subtypes in small cell/neuroendocrine bladder cancer.
Authors
Woonyoung Choi
Johns Hopkins School of Medicine, Baltimore, MD
Woonyoung Choi , Mingxiao Feng , Gabriel Epstein , Jean H. Hoffman-Censits , Max R. Kates , Bogdan Czerniak , Eva Comperat , Andres Matoso , Seungchan Kim , David James McConkey
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 568)
DOI
10.1200/JCO.2023.41.6_suppl.568
Abstract #
568
Poster Bd #
N11
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Genomic analysis and prediction of therapeutic vulnerabilities of small cell lung cancer from rovalpituzumab tesirine phase III trial (MERU).
First Author: Weilong Zhao
Poster
2022 ASCO Genitourinary Cancers Symposium
Tumor genomic landscape in smokers compared to non-smoker patients with locally advanced or metastatic urothelial carcinoma.
First Author: Nishita Tripathi
Poster
2018 Genitourinary Cancers Symposium
Molecular profiles of small cell bladder and prostate cancer and comparisons with small cell lung cancer.
First Author: Nancy Ann Dawson
Poster
2024 ASCO Annual Meeting
SWOG S2012: Randomized phase II/III trial of first line platinum (P)/etoposide (E) with or without atezolizumab (NSC #783608) in patients with advanced or metastatic poorly differentiated extrapulmonary neuroendocrine carcinomas (NEC).
First Author: David Bing Zhen